MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
Regulatory Affairs
The GLP-1 Dilemma: Ireland’s Battle Over Blockbuster Weight-Loss Drugs
The Health Service Executive (HSE) is facing intense budgetary pressure as clinical demand for GLP-1 obesity medications skyrockets. We break down the restrictive funding, the "dreadful dichotomy" of access, and the surge in illegal online sales.
MedTech
A Tale of Two Systems: Why US Healthcare Costs are Skyrocketing and What it Means for Ireland
A recent PwC report warns that US commercial healthcare costs will surge by 9% in 2027. We compare the driving forces behind this unprecedented American inflation with the pressures currently facing the Irish healthcare system.
Industry
The Ultimate Guide to Startup Funding in Ireland (2026)
Navigating the Irish startup ecosystem? Discover our comprehensive, step-by-step breakdown of seed funding, accelerator programs, and grants available from Enterprise Ireland, LEO, NDRC, and more in 2026.
MedTech
Emerging Pharma Companies in Ireland to Watch in 2026
Discover the top 5 high-growth Irish life science, biotech, and medtech companies transforming the healthcare landscape. From Enterprise Ireland backed startups to global scale-ups, these are the emerging leaders of 2026.
Industry
Ireland Unveils €460m Investment in Seven New "Rinn" Research Centres
The Irish Government, led by Minister James Lawless, has announced a historic €460 million investment to establish seven new national research and innovation hubs across critical sectors like AI, Pharma, and Quantum Science.
Regulatory Affairs
FDA 21 CFR Part 211 vs. EU GMP Annex 1: Key Differences
A comprehensive breakdown of the core differences between US FDA 21 CFR Part 211 and EU GMP Annex 1 for sterile and non-sterile pharmaceutical manufacturing.
Regulatory Affairs
CAPA vs. Root Cause Analysis (RCA) in Pharma
Understanding the critical distinction between Root Cause Analysis (RCA) and Corrective and Preventive Actions (CAPA) in pharmaceutical quality management systems.
Regulatory Affairs
AQL vs. RQL: Choosing the Right Sampling Plan
A technical guide to understanding Acceptable Quality Limit (AQL) versus Rejectable Quality Limit (RQL) in pharmaceutical statistical sampling and batch release.
LinkedIn
A Systematic LinkedIn Strategy for Small Pharma and Biotech Firms
A structured, step-by-step report on how small and emerging life science firms can leverage LinkedIn to build corporate reputation, increase brand awareness, and attract investors without massive marketing budgets.
Biotechnology
Life Science PR: Why Public Relations and Social Media Management is Critical for Pharma
A comprehensive guide on why Life Science PR is essential for pharmaceutical and biotech firms, how to manage corporate reputation, and critical social media guidelines employees must follow before publishing on LinkedIn.
Industry
Upcoming Event: Lunch & Learn at ENGINE by Innovate Limerick
An upcoming event is happening on June 17th for a free networking luncheon at ENGINE as part of the Pathway to Innovate Programme. Discover local and European supports, funding opportunities, and expert resources.